Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H29N3O4.ClH |
| Molecular Weight | 471.976 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O[C@@H](CNC1=CC=C(CCNC[C@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1)C3=CC=CC=C3
InChI
InChIKey=QQPHRRSYJMOQOC-DKIIUIKKSA-N
InChI=1S/C25H29N3O4.ClH/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19;/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29);1H/t24-,25-;/m0./s1
| Molecular Formula | C25H29N3O4 |
| Molecular Weight | 435.5155 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Milveterol (also known as GSK159797) was developed as a longer-acting beta2 adrenoceptor agonist for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Milveterol completed phase II clinical trials for asthmatic subjects. However further development of the drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends. | 2015-05-28 |
|
| A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD. | 2012-01-15 |
|
| Novel bronchodilators in asthma. | 2010-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00358488
GSK159797 (10, 15, and 20mcg) following dosing for 14 days
Route of Administration:
Respiratory
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:05:32 GMT 2025
by
admin
on
Mon Mar 31 18:05:32 GMT 2025
|
| Record UNII |
1D1MD355SJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1940832
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
1D1MD355SJ
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
C77936
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
DTXSID50230335
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
804518-03-4
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
11225217
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
SS-26
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY | |||
|
300000044610
Created by
admin on Mon Mar 31 18:05:32 GMT 2025 , Edited by admin on Mon Mar 31 18:05:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |